Award
National Institute of Neurological Disorders and Stroke 5R01NS138410-02
Mitigation of Cerebral Infarct Growth in Acute Ischemic Stroke Using a Novel Blood Substitute
Recipient
National Institute of Neurological Disorders and Stroke (NINDS), part of the NIH
Award Amount
$596,070.00
Ceiling
$596,070.00
Awarded
June 27, 2025
Identifier
5R01NS138410-02
Research project funded by NINDS to study a synthetic blood substitute to reduce brain damage from stroke, with an award amount of approximately $596,070 for fiscal year 2025.
Description
This project involves studying a new synthetic blood substitute (Sanguinate®) designed to open dormant blood vessels and deliver oxygen to brain regions affected by stroke. The research aims to reduce infarct volume and reperfusion injury, with potential for deployment in emergency settings.